The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer.
Chen H, Huang D, Lin G, Yang X, Zhuo M, Chi Y, Zhai X, Jia B, Wang J, Wang Y, Li J, An T, Wu M, Wang Z, Zhao J.
Chen H, et al. Among authors: wang j, wang z, wang y.
Cancer Med. 2022 Oct;11(19):3581-3592. doi: 10.1002/cam4.4739. Epub 2022 Apr 8.
Cancer Med. 2022.
PMID: 35394121
Free PMC article.